Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
A CCR2+ myeloid cell niche required for pancreatic β cell growth
Kristin Mussar, Stephanie Pardike, Tobias M. Hohl, Gary Hardiman, Vincenzo Cirulli, Laura Crisa
Kristin Mussar, Stephanie Pardike, Tobias M. Hohl, Gary Hardiman, Vincenzo Cirulli, Laura Crisa
View: Text | PDF
Research Article Development Endocrinology

A CCR2+ myeloid cell niche required for pancreatic β cell growth

  • Text
  • PDF
Abstract

Organ-specific patterns of myeloid cells may contribute tissue-specific growth and/or regenerative potentials. The perinatal stage of pancreas development marks a time characterized by maximal proliferation of pancreatic islets, ensuring the maintenance of glucose homeostasis throughout life. Ontogenically distinct CX3CR1+ and CCR2+ macrophage populations have been reported in the adult pancreas, but their functional contribution to islet cell growth at birth remains unknown. Here, we uncovered a temporally restricted requirement for CCR2+ myeloid cells in the perinatal proliferation of the endocrine pancreatic epithelium. CCR2+ macrophages are transiently enriched over CX3CR1+ subsets in the neonatal pancreas through both local expansion and recruitment of immature precursors. Using CCR2-specific depletion models, we show that loss of this myeloid population leads to a striking reduction in β cell proliferation, dysfunctional islet phenotypes, and glucose intolerance in newborns. Replenishment of pancreatic CCR2+ myeloid compartments by adoptive transfer rescues these defects. Gene profiling identifies pancreatic CCR2+ myeloid cells as a prominent source of IGF2, which contributes to IGF1R-mediated islet proliferation. These findings uncover proproliferative functions of CCR2+ myeloid subsets and identify myeloid-dependent regulation of IGF signaling as a local cue supporting pancreatic proliferation.

Authors

Kristin Mussar, Stephanie Pardike, Tobias M. Hohl, Gary Hardiman, Vincenzo Cirulli, Laura Crisa

×

Figure 2

Localization of CCR2+ myeloid cells in the pancreas.

Options: View larger image (or click on image) Download as PowerPoint
Localization of CCR2+ myeloid cells in the pancreas.
(A) Pancreatic sect...
(A) Pancreatic sections from E14.5, P1, and adult CCR2WT/RFP mice, stained for RFP to visualize CCR2+ cells in situ. (B–D) Pancreatic sections from P1 CCR2WT/RFP mice stained for RFP, insulin, and the epithelial marker EpCAM. (E–H) The same tissue sections stained for RFP, insulin, and the vascular markers CD31 (E) and collagen IV (F and G), or the epithelial marker E-cadherin and the macrophage marker F480 (H). CCR2–RFP+ cells occupy the interacinar and peri-islet interstitial space (B–D), outline the extraluminal side of blood vessels (E and F, arrowheads), or line Ep-CAM+ and E-cadherin+ epithelial clusters (G and H, arrowheads). Most CCR2+ cells coexpress F480 (H, arrowheads). Scale bars: 50 μm (A); 40 μm (B); 25 μm (C–F); and 20 μm (G and H). Representative of n = 10 experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts